Mad in America
APRIL 15, 2025
Psychiatric medications are often offered as the default solutionbut without complementary options such as therapy, community support, or trauma-informed care, these prescriptions can become long-term crutches rather than bridges to healing. South Koreas mental health crisis is not simply a matter of individual symptoms.
Mad in America
JUNE 19, 2025
House Bill 25-1063 , approved in April 2025, represents one such effort, revealing the intersection of commercial interests, intellectual property concerns, and the pharmaceutical model’s influence on psychedelic policy. The container of community support becomes as important as the medicine itself.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
DECEMBER 20, 2023
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Moore: The last couple of questions are related to the pharmaceutical industry. Thank you to all of you who took the time and trouble to send in your questions.
Mad in America
OCTOBER 31, 2023
Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. This notable gap has raised some suspicion that the necessary research has not merely been overlooked but deliberately avoided.
Mad in America
AUGUST 3, 2024
Iatrogenesis is social when medicine as an institution and a bureaucracy creates ill-health by increasing stress; by subverting autonomy and community support; and by depoliticizing sources of illness. For Illich, the iatrogenesis of modern medicine is clinical when harm to individuals results specifically from medical treatment.
Expert insights. Personalized for you.
96 
Let's personalize your content